Clarity Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 29 Nov 23 | SellUS$256,420 | Charles Morgan | Individual | 300,000 | US$0.85 | |
| 01 Sep 23 | SellUS$3,207,650 | Charles Morgan | Individual | 5,000,000 | US$0.64 |
Insider Trading Volume
Insider-Käufe: Die Daten reichen nicht aus, um festzustellen, ob Insider in den letzten 3 Monaten mehr Aktien gekauft als verkauft haben.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| State or Government | 3.599.920 | 1,18 % |
| Institutions | 14.536.052 | 4,75 % |
| Private Companies | 28.396.390 | 9,27 % |
| Individual Insiders | 54.094.405 | 17,7 % |
| General Public | 205.673.233 | 67,1 % |
Verwässerung von Anteilen: Die Aktionäre wurden im vergangenen Jahr verwässert, wobei die Zahl der ausstehenden Aktien um 17.6% stieg.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 17.911.280 | US$32.2m | 0 % | no data | |||
| 14.066.660 | US$25.3m | 0 % | no data | |||
| 9.247.447 | US$16.6m | 0 % | 0,36 % | |||
| 7.803.450 | US$14.0m | 0 % | no data | |||
| 7.487.340 | US$13.5m | 0 % | no data | |||
| 6.600.041 | US$11.9m | -4,35 % | no data | |||
| 6.262.820 | US$11.3m | 0 % | no data | |||
| 6.065.800 | US$10.9m | 0 % | no data | |||
| 5.004.543 | US$9.0m | 0 % | no data | |||
| 3.896.280 | US$7.0m | 0 % | no data | |||
| 3.599.920 | US$6.5m | 0 % | no data | |||
| 3.116.000 | US$5.6m | 0 % | no data | |||
| 2.946.500 | US$5.3m | 0 % | no data | |||
| 2.768.320 | US$5.0m | 0 % | no data | |||
| 1.801.304 | US$3.2m | 0 % | no data | |||
| 1.125.000 | US$2.0m | 0 % | no data | |||
| 520.000 | US$935.0k | 333 % | no data | |||
| 234.235 | US$421.1k | 0 % | 0,13 % | |||
| 120.000 | US$215.8k | 0 % | no data | |||
| 25.000 | US$44.9k | 0 % | 100,0 % | |||
| 24.827 | US$44.7k | 0 % | no data |